Shigeki Sasaki

Prof. Shigeki Sasaki

Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

16 January 1995 in Tetrahedron Letters
Verified
Journal Article
Closed access
FNFumi Nagatsugi
Fumi Nagatsugi
KUKengo Uemura
Kengo Uemura
SNShouji Nakashima
Shouji Nakashima
MMMinoru Maeda
Minoru Maeda
SSShigeki Sasaki
Shigeki Sasaki

27 April 2006 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
MAMonsur Ali
Monsur Ali
MOMotoi Oishi
Motoi Oishi
FNFumi Nagatsugi
Fumi Nagatsugi
KMKenya Mori
Kenya Mori
YNYukio Nagasaki
Yukio Nagasaki
SSShigeki Sasaki
Shigeki Sasaki

31 August 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
HOHidenori Okamura
Hidenori Okamura
YTYosuke Taniguchi
Yosuke Taniguchi
SSShigeki Sasaki
Shigeki Sasaki

18 September 2012 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
YTYosuke Taniguchi
Yosuke Taniguchi
SSShigeki Sasaki
Shigeki Sasaki
Triplex forming oligonucleotides (TFOs) are some of the most promising tools in the antigene strategy for the development of gene targeting therapeutics. However, the stable triplex formation is restricted to the homopurine sequences consisting of purine nucleosides, dG and dA. Therefore, the T or dC nucleoside in the homopurine strand inhibits the stable triplex formation. We have developed W-shaped nucleoside analogues (WNAs) for the formation of the unnatural type triplex DNA, with sequences containing the interrupting site in an antiparallel triplex formation. In the present study, we tested the antigene effect of TFOs having WNA-βT, which increased the stability of the triplex formation with a target sequence including the TA interrupting site. We designed the GU TFO (WNA) and GU TFO (natural) for targeting sequences of the Bcl-2 or survivin oncogene. The gel shift assay showed that the TFO (WNA) formed more stable triplexes than the natural TFO. Remarkably, the Bcl-2- or survivin-targeted TFO (WNA) inhibited the cell proliferation and induced a caspase-dependent apoptosis. It was confirmed that the survivin-targeted TFO (WNA) more effectively decreased the number of survivin products in the A549 cell than the natural TFOs.

7 June 2011 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
SSShigeki Sasaki
Shigeki Sasaki
KOKazumitsu Onizuka
Kazumitsu Onizuka
YTYosuke Taniguchi
Yosuke Taniguchi
As the knowledge of the biological functions of RNA expands, the demand for research tools to investigate intracellular RNA is increasing. Oligonucleotides can be rationally designed for the target RNA sequence, and therefore, have become a reliable platform for the development of specific molecules for RNA. The chemical modification of RNA has a strong impact on RNA research; the fluorescent labeling of RNA is useful to monitor RNA production, processing, relocation in the cell, interaction with other intracellular components and degradation, etc. Chemical modification may affect the RNA function through a variety of pathways, and therefore, would be potentially useful for biological research, therapeutic approach and artificial manipulation of the RNA function. This tutorial review starts with an introduction of the biological relevance of modified RNA, and focuses on the recent progress of the oligodeoxynucleotide probes for the covalent modifications of RNA. The prospects of this new technology are also discussed.